Reckitt Benckiser Group (RBGLY) Expected to Announce Quarterly Earnings on Thursday

Reckitt Benckiser Group (OTCMKTS:RBGLYGet Free Report) is anticipated to issue its results before the market opens on Thursday, March 5th. Analysts expect the company to announce earnings of $0.5110 per share and revenue of $9.8490 billion for the quarter.

Reckitt Benckiser Group Trading Down 0.3%

OTCMKTS:RBGLY opened at $16.41 on Wednesday. The company has a 50-day moving average of $16.81 and a 200-day moving average of $15.96. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.37 and a current ratio of 0.56. Reckitt Benckiser Group has a twelve month low of $11.99 and a twelve month high of $16.80.

Analyst Ratings Changes

RBGLY has been the topic of several recent research reports. Jefferies Financial Group restated a “hold” rating on shares of Reckitt Benckiser Group in a research report on Wednesday, January 7th. Citigroup assumed coverage on Reckitt Benckiser Group in a report on Wednesday, January 14th. They issued a “buy” rating on the stock. Royal Bank Of Canada lowered Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a research report on Wednesday, January 14th. Morgan Stanley downgraded Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a report on Monday, December 15th. Finally, Barclays raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 1st. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy”.

View Our Latest Stock Report on RBGLY

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.

Featured Stories

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.